Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;35(2):396-403.
doi: 10.2337/dc11-1588. Epub 2011 Dec 30.

Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies

Andre Pascal Kengne  1 , G David Batty, Mark Hamer, Emmanuel Stamatakis, Sébastien Czernichow
Affiliations

Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies

Andre Pascal Kengne et al. Diabetes Care. 2012 Feb.

Abstract

Objective: C-reactive protein (CRP) is associated with the risk of cardiovascular disease (CVD); whether the effects are modified by diabetes status still is unclear. This study investigated these issues and assessed the added value of CRP to predictions.

Research design and methods: Participants were drawn from representative samples of adults living in England and Scotland. Cox proportional hazards regression models were used to relate baseline plasma CRP with all-cause and CVD mortality during follow-up in men and women with and without diabetes. The added value of CRP to the predictions was assessed through c-statistic comparison and relative integrated discrimination improvement.

Results: A total of 25,979 participants (4.9% with diabetes) were followed for a median of 93 months, during which period there were 2,767 deaths (957 from CVD). CRP (per SD log(e)) was associated with a 53% (95% CI 43-64) and 43% (38-49) higher risk of cardiovascular and all-cause mortality, respectively. These associations were log linear and did not differ according to diabetes status (both P ≥ 0.08 for interaction), sex, and other risk factors. Adding CRP to conventional risk factors improved predictions overall and separately by diabetes status but not for CVD mortality, although such improvements only were marginal based on several discrimination statistics.

Conclusions: The association between CRP and CVD was similar across diabetes status, and the effects are broadly similar across levels of other conventional risk factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hazard ratios and 95% CIs for the association between CRP and all-cause (upper panels) and CVD (lower panels) mortality, overall (left column) and in men (middle column) and women (right column) with and without diabetes. Boxes (■) represent the effect estimates (hazard ratio) and the vertical bars represent the 95% CIs (from floating absolute-risk methods) within quintiles of CRP, separately for people with diabetes (broken lines) and those without (solid lines). Cox models are stratified by cohort and adjusted for sex and age. A–F: The hazard ratio for an SD higher loge CRP for people with diabetes versus people without diabetes, the accompanying P value for log linearity of the association (P trend), and the P value for the interaction between diabetes and CRP (P interaction) are all-cause mortality overall 1.53 (95% CI 1.35–1.72; P trend <0.0001) and 1.41 (1.35–1.47; P trend <0.0001; P interaction = 0.08) (A); all-cause mortality in men 1.27 (1.21–1.34; P trend <0.0001) and 1.46 (1.38–1.54; P trend <0.0001; P interaction = 0.56) (B); all-cause mortality in women 1.53 (91.27–1.83; P trend = 0.006) and 1.64 (1.35–1.98; P trend <0.0001; P interaction = 0.06) (C); CVD mortality overall 1.54 (1.28–1.85; P trend <0.0001) and 1.52 (1.42–1.63; P trend <0.0001; P interaction = 0.80) (D); CVD mortality in men 1.41 (1.29–1.54; P trend = 0.0001) and 1.51 (1.38–1.66; P trend <0.0001; P interaction = 0.61) (E); and CVD mortality in women 1.44 (1.07–1.93; P trend = 0.47) and 1.81 (1.36–2.39; P trend <0.0001; P interaction = 0.98) (F).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dent TH. Predicting the risk of coronary heart disease: II: the role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction. Atherosclerosis 2010;213:352–362 - PubMed
    1. Hingorani AD, Shah T, Casas JP, Humphries SE, Talmud PJ. C-reactive protein and coronary heart disease: predictive test or therapeutic target? Clin Chem 2009;55:239–255 - PubMed
    1. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387–1397 - PubMed
    1. Keavney B. C reactive protein and the risk of cardiovascular disease. BMJ 2011;342:d144. - PubMed
    1. Fortmann SP, Ford E, Criqui MH, et al. ; Centers for Disease Control and Prevention; American Heart Association CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to clinical and public health practice: report from the population science discussion group. Circulation 2004;110:e554–e559 - PubMed

Substances